Ascendo Biotechnology, Inc.
1 known investors
Find your way into Ascendo Biotechnology, Inc.
Sign up to see every warm intro you have to Ascendo Biotechnology, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ascendo Biotechnology, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ascendo Biotechnology is a clinical-stage biopharmaceutical company developing innate immune checkpoint therapies for cancer and autoimmune disease. Its lead candidate, ASD141, is in Phase I trials for solid tumors resistant to existing treatments.
Investors · 1
Frequently asked questions
- What does Ascendo Biotechnology, Inc. do?
- Ascendo Biotechnology is a clinical-stage biopharmaceutical company developing innate immune checkpoint therapies for cancer and autoimmune disease. Its lead candidate, ASD141, is in Phase I trials for solid tumors resistant to existing treatments.
- Who are Ascendo Biotechnology, Inc.'s investors?
- Ascendo Biotechnology, Inc.'s investors include Axil Capital.
